HER2positive Archives

2023 ESMO Congress Reveals YOUNGBC-21 Study Results

By Mourabit Halima 2023.12.07

Editor's note: HER2-positive metastatic breast cancer (HER2+ MBC) has seen the emergence of several new drugs, but the combination of Pyrotinib with dual targeting therapy remains the preferred first-line option.…

Dr. Tao Sun & Dr. Yehui Shi: Eribulin Combination Therapy Shines for Breast Cancer Patients, Providing More Treatment Options

By Mourabit Halima 2023.12.05

Editor's Note: Breast cancer has become the most common malignant tumor globally, with approximately 30% to 40% of early-stage breast cancer patients ultimately progressing to advanced breast cancer.At this year's…

ESMO 2023: Prof. Feng Wang – “Combination Targeted Immunotherapy” Opens a New Era of Precision Treatment for Esophageal and Gastric Cancer in China

By Mourabit Halima 2023.12.04

Editor's note: The 2023 ESMO Annual Meeting took place in Madrid, Spain, from October 20th to 24th. As a prestigious annual event in the field of oncology, it unveils cutting-edge…